{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T01:38:43Z","timestamp":1745458723168},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1245\/s10434-012-2401-8","type":"journal-article","created":{"date-parts":[[2012,5,15]],"date-time":"2012-05-15T23:04:06Z","timestamp":1337123046000},"page":"3913-3918","source":"Crossref","is-referenced-by-count":20,"title":["Therapeutic Lymph Node Dissection in Melanoma: Different Prognosis for Different Macrometastasis Sites?"],"prefix":"10.1245","volume":"19","author":[{"given":"K. P.","family":"Wevers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bastiaannet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. P. A. M.","family":"Poos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. J.","family":"van Ginkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. T.","family":"Plukker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. J.","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,17]]},"reference":[{"key":"2401_CR1","unstructured":"Dutch Comprehensive Cancer Centers. 2011. http:\/\/ikcnet.nl\/ . Accessed August 2011."},{"key":"2401_CR2","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ejca.2010.11.020","volume":"47","author":"MA Aa van der","year":"2011","unstructured":"van der Aa MA, de Vries E, Hoekstra HJ, Coebergh JW, Siesling S. Sociodemographic factors and incidence of melanoma in the Netherlands, 1994\u20132005. Eur J Cancer. 2011;47:1056\u201360.","journal-title":"Eur J Cancer."},{"key":"2401_CR3","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199\u2013206.","journal-title":"J Clin Oncol."},{"key":"2401_CR4","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S1470-2045(05)70283-7","volume":"6","author":"AB Francken","year":"2005","unstructured":"Francken AB, Bastiaannet E, Hoekstra HJ. Follow-up in patients with localised primary cutaneous melanoma. Lancet Oncol. 2005;6:608\u201321.","journal-title":"Lancet Oncol."},{"key":"2401_CR5","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1200\/JCO.2009.27.1627","volume":"28","author":"CM Balch","year":"2010","unstructured":"Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Ding S, Byrd DR, et al. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol. 2010;28:2452\u20139.","journal-title":"J Clin Oncol."},{"key":"2401_CR6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00000658-199609000-00002","volume":"224","author":"CM Balch","year":"1996","unstructured":"Balch CM, Soong SJ, Bartolucci AA, Urist MM, Karakousis CP, Smith TJ, et al. Efficacy of an elective regional lymph node dissection of 1 to 4\u00a0mm thick melanomas for patients 60\u00a0years of age and younger. Ann Surg. 1996;224:255\u201363.","journal-title":"Ann Surg."},{"issue":"9105","key":"2401_CR7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(97)08260-3","volume":"351","author":"N Cascinelli","year":"1998","unstructured":"Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet. 1998;351(9105):793\u20136.","journal-title":"Lancet."},{"key":"2401_CR8","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1046\/j.1365-2168.2000.01439.x","volume":"87","author":"TM Hughes","year":"2000","unstructured":"Hughes TM, A\u2019Hern RP, Thomas JM. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg. 2000;87:892\u2013901.","journal-title":"Br J Surg."},{"key":"2401_CR9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejso.2006.10.032","volume":"33","author":"AC Akkooi van","year":"2007","unstructured":"van Akkooi AC, Bouwhuis MG, van Geel AN, Hoedemaker R, Verhoef C, Grunhagen DJ, et al. Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma. Eur J Surg Oncol. 2007;33:102\u20138.","journal-title":"Eur J Surg Oncol."},{"key":"2401_CR10","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on cancer melanoma staging system. J Clin Oncol. 2001;19:3622\u201334.","journal-title":"J Clin Oncol."},{"key":"2401_CR11","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1245\/s10434-009-0629-8","volume":"16","author":"S Kruijff","year":"2009","unstructured":"Kruijff S, Bastiaannet E, Kobold AC, van Ginkel RJ, Suurmeijer AJ, Hoekstra HJ. S-100B concentrations predict disease-free survival in stage III melanoma patients. Ann Surg Oncol. 2009;16:3455\u201362.","journal-title":"Ann Surg Oncol."},{"key":"2401_CR12","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/SLA.0b013e318214beba","volume":"253","author":"R Murali","year":"2011","unstructured":"Murali R, Desilva C, Thompson JF, Scolyer RA. Factors predicting recurrence and survival in sentinel lymph node\u2013positive melanoma patients. Ann Surg. 2011;253:1155\u201364.","journal-title":"Ann Surg."},{"key":"2401_CR13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/archderm.144.4.515","volume":"144","author":"AM Lachiewicz","year":"2008","unstructured":"Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the surveillance, epidemiology, and end results (SEER) program. Arch Dermatol. 2008;144:515\u201321.","journal-title":"Arch Dermatol."},{"key":"2401_CR14","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1200\/JCO.2008.20.1822","volume":"27","author":"E Bastiaannet","year":"2009","unstructured":"Bastiaannet E, Wobbes T, Hoekstra OS, van der Jagt EJ, Brouwers AH, Koelemij R, et al. Prospective comparison of [18F] fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment. J Clin Oncol. 2009;27:4774\u201380.","journal-title":"J Clin Oncol."},{"key":"2401_CR15","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ejso.2008.10.012","volume":"35","author":"HP Poos","year":"2009","unstructured":"Poos HP, Kruijff S, Bastiaannet E, van Ginkel RJ, Hoekstra HJ. Therapeutic groin dissection for melanoma: risk factors for short term morbidity. Eur J Surg Oncol. 2009;35:877\u201383.","journal-title":"Eur J Surg Oncol."},{"key":"2401_CR16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ctrv.2004.09.005","volume":"31","author":"E Bastiaannet","year":"2005","unstructured":"Bastiaannet E, Beukema JC, Hoekstra HJ. Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications. Cancer Treat Rev. 2005;31:18\u201326.","journal-title":"Cancer Treat Rev."},{"key":"2401_CR17","doi-asserted-by":"crossref","unstructured":"Henderson MA, Burmeister B, Thompson JF, Di Iulio J, Fisher R, Hong A, et al. Adjuvant radiotherapy and regional lymph node field control in melanoma patients after lymphadenectomy: results of an intergroup randomized trial (ANZMTG 01.02\/TROG 02.01). Ann Surg Oncol. 2009;27(18S):LBA9084.","DOI":"10.1200\/jco.2009.27.18s.lba9084"},{"key":"2401_CR18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1245\/s10434-007-9641-z","volume":"15","author":"CR Rossi","year":"2008","unstructured":"Rossi CR, Mocellin S, Pasquali S, Pilati P, Nitti D. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma. Ann Surg Oncol. 2008;15:310\u20135.","journal-title":"Ann Surg Oncol."},{"key":"2401_CR19","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1002\/cncr.24290","volume":"115","author":"Y Xing","year":"2009","unstructured":"Xing Y, Badgwell BD, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, et al. Lymph node ratio predicts disease-specific survival in melanoma patients. Cancer. 2009;115:2505\u201313.","journal-title":"Cancer."},{"key":"2401_CR20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jso.22051","volume":"105","author":"AC Berger","year":"2012","unstructured":"Berger AC, Fierro M, Kairys JC, Berd D, Sato T, Andrel J, et al. Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma. J Surg Oncol. 2012;105:15\u201320.","journal-title":"J Surg Oncol."},{"key":"2401_CR21","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1245\/s10434-011-1801-5","volume":"18","author":"SP Prens","year":"2011","unstructured":"Prens SP, van der Ploeg AP, van Akkooi AC, van Montfort CA, van Geel AN, de Wilt JH, et al. Outcome after therapeutic lymph node dissection in patients with unknown primary melanoma site. Ann Surg Oncol. 2011;18:3586\u201392.","journal-title":"Ann Surg Oncol."},{"key":"2401_CR22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ejso.2011.05.003","volume":"37","author":"M Vries de","year":"2011","unstructured":"de Vries M, Speijers MJ, Bastiaannet E, Plukker JT, Brouwers AH, van Ginkel RJ, et al. Long-term follow-up reveals that ulceration and sentinel lymph node status are the strongest predictors for survival in patients with primary cutaneous melanoma. Eur J Surg Oncol. 2011;37:681\u20137.","journal-title":"Eur J Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2401-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T19:39:45Z","timestamp":1561750785000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-012-2401-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,17]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["2401"],"URL":"https:\/\/doi.org\/10.1245\/s10434-012-2401-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,17]]}}}